Abbreviations used in this paper: GEF, guanine nucleotide exchange factor; GDP, guanosine 5′-diphosphate; lgl, lethal giant larvae; SC, synthetic complete; YPD, yeast peptone dextrose.

Introduction
============

Cell polarization is important for processes as diverse as cell movement, axonal outgrowth, secretion of hormones, and cell differentiation. Polarization requires the vectorial delivery of secretory vesicles to, and their subsequent fusion with, the plasma membrane. The yeast *Saccharomyces cerevisiae* is an excellent model organism to study mechanisms of polarization because it propagates through the polarized outgrowth of a bud.

In *S. cerevisiae*, the polarized transport of secretory vesicles to the bud tip or, later in the cell cycle, to the mother-bud neck, depends on the actin cytoskeleton and the actin-based myosin motor protein Myo2p ([@bib35]; [@bib23]). An important factor in this transport event is Sec4p, the founding member of the Rab branch of the Ras superfamily of small GTPases ([@bib36]; [@bib11]). Rab proteins are so-called molecular switches, which cycle between an "on" (GTP bound) and "off" (guanosine 5′-diphosphate \[GDP\] bound) state. This GTPase switch is influenced by guanine nucleotide exchange factors (GEFs), which trigger the binding of GTP, thus activating the Rabs, and GTPase-activating proteins, which accelerate hydrolysis of the bound GTP to GDP, inactivating the GTPase (for review see [@bib34]; [@bib37]). Rabs are thought to accomplish their function by binding specific effector proteins in their GTP-bound state (for review see [@bib34]; [@bib50]).

Sec4p was found in a screen for mutants that block exocytosis and accumulate secretory vesicles at a restrictive temperature ([@bib31]). Mutants of *SEC2*, the Sec4p GEF, show an accumulation of vesicles randomly distributed throughout the cell, implying that the activation of Sec4p by Sec2p directs the polarized delivery of secretory vesicles ([@bib45]). Supporting the view that activated GTP-Sec4p promotes Myo2p-dependent movement of secretory vesicles along actin cables, Sec4p was found to coimmunoprecipitate with Myo2p ([@bib44]).

Although mutations in *SEC4* tightly block secretion ([@bib31]), mutations in actin (*ACT1*) and *MYO2* depolarize secretion and cell surface growth but do not block secretion ([@bib12]; [@bib23]). These results imply that Sec4p has at least one function in addition to its role in polarized vesicle delivery. A clue toward one such function came from the identification of Sec15p as a Sec4p effector ([@bib15]). Sec15p is a subunit of the exocyst, an octameric complex required for tethering secretory vesicles to the plasma membrane in preparation for fusion ([@bib42]; [@bib14]). Sec8p, another exocyst subunit, was recently found to coimmunoprecipitate with Sec4p, suggesting that the entire exocyst complex acts downstream of Sec4p ([@bib43]). Furthermore, Sec4p is required for the assembly of the exocyst complex ([@bib15]).

It has become increasingly clear that Rab GTPases interact with a variety of effectors in order to fulfill their functions in the cell (for review see [@bib50]; [@bib7]). Combined with the evidence that Sec4p regulates both the transport of secretory vesicles to and fusion with the plasma membrane, it seems likely that there are still more Sec4p effectors to be found. The identification of additional effectors would provide important new insights into the molecular function of Sec4p.

Lethal giant larvae (lgl) was first identified as a tumor suppressor gene in the fly *Drosophila melanogaster* (for review see [@bib49]; [@bib3]). *lgl* mutant flies were found to develop malignant tumors in the larval brain and imaginal discs that appear to result from a loss of cell polarity. Subsequently, homologues of lgl have been identified in many organisms, ranging from yeast to humans (for review see [@bib3]). Because lgl family members are often found to be associated with the actin cytoskeleton, it has been argued that the observed polarity defects in cells bearing *lgl* mutations are caused by defects in the actin cytoskeleton ([@bib40]; [@bib33]; for review see [@bib2]). However, data are accumulating that lgl family members function in polarized membrane traffic. *D. melanogaster* lgl is required for the targeting of proteins to the basolateral membrane ([@bib33]), and the yeast homologues of lgl, Sro7p, and Sro77p (also known as Sop1p and Sop2p, respectively) are redundantly required for exocytosis ([@bib25]). Sro7p and Sro77p are 55% identical ([@bib22]; [@bib25]). Both proteins were originally identified as high-copy suppressors of *rho3*Δ ([@bib22]), a Rho GTPase required for actin cytoskeleton polarity and polarized exocytosis ([@bib30]; [@bib19]; [@bib1]).

In this study, we describe the identification of Sro7p as an effector of Sec4p. Sro7p from yeast extracts as well as purified Sro7p interact specifically with the GTP-bound form of Sec4p. Sro7p was found to coimmunoprecipitate with Sec4p, demonstrating that the interaction we observed in vitro also occurs in vivo. Moreover, we found that Sro7p, Sec4p, and the t-SNARE Sec9p can form a ternary complex, suggesting that Sec4p regulates SNARE function through Sro7p. In agreement with this, genetic analysis shows that Sro7p shares a function with the exocyst downstream of Sec4p.

Results
=======

Identification of Sec4p effectors
---------------------------------

We used an affinity purification approach to identify potential Sec4p effectors. GST-tagged Sec4p was purified from bacteria ([Fig. 1, A and B](#fig1){ref-type="fig"}). GST-Sec4p bound to glutathione beads was loaded with either GTPγS or GDP and, subsequently, incubated with wild-type yeast extract. As a control, GST bound to beads was also incubated with extract. The beads were washed several times, and bound proteins were eluted with high salt (see Sec4p affinity chromatography for details). Despite the presence of background proteins ([Fig. 1](#fig1){ref-type="fig"} C, GST lane), differences could be readily detected between the protein bands in the GST-Sec4p-GTPγS and GST-Sec4p-GDP affinity chromatography samples ([Fig. 1](#fig1){ref-type="fig"} C). The protein mixture of each sample was TCA precipitated and subjected to mass spectrometry analysis. Common background proteins were identified by their abundance in both samples and by a survey of published literature ([@bib16]). By definition, an effector binds more strongly to the GTP-bound form of a GTPase than to the GDP-bound form. One measure of the relative abundance of a protein in a protein mixture examined by mass spectrometry is the percentage of residues in the protein sequence that are represented by at least one peptide. We considered all proteins with an at least threefold higher coverage in the sample retrieved from the GTPγS-bound versus the GDP-bound form of Sec4p to be potential Sec4p effectors. Among the identified proteins meeting these criteria was Sro7p, a yeast member of the lgl family of proteins.

![**Affinity purification of Sec4p-binding proteins.** (A) GST-Sec4p (Sec4) and GST were purified from *E. coli*, subjected to SDS-PAGE electrophoresis, and visualized by Coomassie staining. (B) GST-Sec4p (Sec4) and GST were purified from *E. coli* and subjected to Western blot analysis using α-Sec4 antibody. (C) Glutathione beads coated with GST-Sec4p (Sec4) loaded with either GTPγS or GDP were incubated with a wild-type yeast cell extract (strain NY 1210). Copurifying proteins were subsequently eluted, subjected to SDS-PAGE electrophoresis, and silver stained. Only GST was used as a control (right). Proteins that exhibit preferential binding to GTPγS-Sec4p are indicated with arrows; arrowheads indicate proteins that preferentially bind to GDP-Sec4p. Asterisks indicate the GST-Sec4p and GST proteins.](jcb1720055f01){#fig1}

Sro7p binds preferably to the activated, GTP-bound form of Sec4p
----------------------------------------------------------------

As shown in [Table 1](#tbl1){ref-type="table"}, Sro7p displayed fivefold higher mass spectrometry coverage when Sec4p was GTPγS bound compared with its GDP-bound form. To validate these findings, we repeated the affinity chromatography with an extract from yeast cells expressing an integrated HA~3~-tagged allele of Sro7p. The tag did not interfere with the functionality of the protein, as demonstrated by its ability to suppress the cold sensitivity of an *sro7*Δ *sro77*Δ double mutant and the salt sensitivity of an *sro7*Δ mutant strain ([Fig. 2](#fig2){ref-type="fig"} A and not depicted). Western blot analysis confirmed that Sro7-HA~3~p migrates at its expected molecular weight ([Fig. 2](#fig2){ref-type="fig"} B). An extract of this strain was incubated with GST-Sec4p in its different nucleotide-bound states or in the nucleotide-free state, GST-Ypt1p and GST. The latter two were used as specificity controls. Ypt1p is another member of the Rab GTPase family that is required for ER-to-Golgi transport in *S. cerevisiae* ([@bib21]). To test whether this method indeed distinguishes the different nucleotide-bound states and the nucleotide-free state of Sec4p, we used antibodies to probe for Sec2p and Sec15p. As mentioned above, Sec15p is the only previously documented effector of Sec4p, which was shown by two-hybrid analysis to bind preferentially to a hydrolysis-deficient (GTP locked) allele of Sec4p ([@bib15]). Sec2p is the exchange factor of Sec4p, which preferentially binds to the nucleotide-free state of Sec4p and, with lesser affinity, to the GDP-bound form of Sec4p ([@bib45]; [@bib32]). As shown in [Fig. 2](#fig2){ref-type="fig"} C, Sec15p binds specifically to the GTPγS-bound form of GST-Sec4p (α-Sec15), whereas Sec2p binds with the highest affinity to the nucleotide-free state of GST-Sec4p (α-Sec2), thus confirming the nucleotide specificity of the method. To detect Sro7-HA~3~p, these samples were analyzed by Western blotting with an α-HA antibody. Confirming the result obtained by mass spectrometry, Sro7-HA~3~p was found to bind much more efficiently to the GTPγS-bound form of GST-Sec4p than to its GDP-bound or nucleotide-free state ([Fig. 2](#fig2){ref-type="fig"} C, α-HA).

###### 

**Mass spectrometry results for Sro7p**

  Recovery of Sro7p                GTPγS-Sec4p                GDP-Sec4p
  -------------------------------- -------------------------- --------------------------
  Percentage of protein sequence   9.9                        1.9
  Number of identified peptides    7                          1
  Identified peptides              R.TVFETEINVPQPDYIR.D       R.SSDDNNANHPEHQYTKPTRK.G
                                   R.GDNQSLTMIDLGYTPR.Y       
                                   R.RGPAIIYMENIR.E           
                                   K.YPLAATGLSYISTVEK.N       
                                   K.YITESSVLR.N              
                                   R.VSEFQASLFSTVK.E          
                                   R.SSDDNNANHPEHQYTKPTRK.G   

![**Sro7-HA** ~3~ **p from yeast extracts binds preferentially to GTPγS-Sec4p.** (A) Expression of *SRO7-HA* ~3~ suppresses the cold sensitivity of an *sro7*Δ *sro77*Δ strain. Wild-type (WT), *sro7*Δ *sro77*Δ, and *SRO7-HA* ~3~ sro77Δ yeast strains were spotted in 10-fold dilutions onto YPD media plates and grown at the indicated temperatures. (B) Extracts of a wild-type or *SRO7-HA* ~3~ strain (HA) were subjected to Western blot analysis using an α-HA antibody. Ponceau staining is shown as a loading control. (C) Sro7-HA~3~p binds preferentially to GTPγS-Sec4p. GST-Sec4 (Sec4), GST-Ypt1 (Ypt1), or GST immobilized on glutathione beads were incubated with an extract of an *SRO7-HA* ~3~ strain, and copurifying proteins were subjected to Western blot analysis using the indicated antibodies. GST-Sec4p and GST-Ypt1p were either stripped of nucleotide (NF) or loaded with GTPγS (GTP) or GDP. Ponceau staining of the Western blot is shown as a loading control. The input lanes represent 0.2 and 0.3%, respectively.](jcb1720055f02){#fig2}

Moreover, Sro7-HA~3~p does not bind to GST-Ypt1p or GST ([Fig. 2](#fig2){ref-type="fig"} C, α-HA), establishing the specificity of the Sro7p--Sec4p interaction. Approximately 2--4% of total Sro7-HA~3~p was found to bind to GTPγS-Sec4p in this assay. The amount of Sro7p bound to GTP-Sec4p in this assay exceeds the amount of bound Sec15p ([Fig. 2](#fig2){ref-type="fig"} C, compare α-Sec15 with α-HA). Interestingly, the same amount of Sro7-HA~3~p binds to GTPγS-Sec4p when only half the amount of extract is used (not depicted), suggesting that the amount of activated Sec4p available for Sro7p binding is limiting in this assay. Altogether, our data indicate that Sro7p from yeast extract binds preferentially to the GTP-bound form of Sec4p, confirming the result obtained by mass spectrometry.

Sro7p binds directly to Sec4p
-----------------------------

We next determined whether purified Sro7p and Sec4p bind to each other in the absence of other proteins. Because Sro7p cannot be purified from bacteria (unpublished data), it was purified from yeast using a multistep procedure (see Purification of full-length Sec9 and Sro7 for details). This purification resulted in an Sro7p preparation that appears homogeneous by SDS-PAGE and Coomassie staining ([Fig. 3](#fig3){ref-type="fig"} A) and dissociated from its binding protein, Sec9p ([@bib25]; unpublished data). As shown in [Fig. 3](#fig3){ref-type="fig"} B, purified Sro7p binds to GST-Sec4p preferentially in the presence of GTPγS. The amount of Sro7p bound to GST-Sec4p ranges from ∼5 to 20% of total Sro7p bound to GTPγS-Sec4p, and 1/20--1/10 of this amount bound to the GDP-bound or nucleotide-free Sec4p ([Fig. 3](#fig3){ref-type="fig"} B). The observed binding is specific because Sro7p does not bind to any of the nucleotide-bound and -free forms of GST-Ypt1 or GST alone ([Fig. 3](#fig3){ref-type="fig"} B and not depicted). Thus, purified Sro7p binds to Sec4p in its activated state. Given the strength of the observed interaction ([Fig. 3](#fig3){ref-type="fig"} B) and the purity of Sro7p ([Fig. 3](#fig3){ref-type="fig"} A), we conclude that this interaction is very likely to be direct because any copurifying factor would be substoichiometric.

![**Sro7p binds directly to Sec4p.** (A) Sro7p was purified from yeast using a multistep purification protocol (see Materials and methods). 1 and 1.8 μg of purified Sro7p were subjected to SDS-PAGE analysis and stained with Coomassie. (B) 4 μM GTPγS-, GDP-bound, or nucleotide-free (NF) GST-Sec4 (Sec4) or GST alone in the presence of GTPγS on glutathione beads were incubated with 1 μM of purified Sro7p at 4°C. The beads were pelleted, and bound Sro7p was detected by Western blot analysis with an Sro7p-specific (α-Sro7) antibody. Coomassie staining of the GST fusion proteins as used in this assay is shown as a loading control. The input represents 10% of total Sro7p.](jcb1720055f03){#fig3}

Sro7p and Sec4p interact in vivo
--------------------------------

To test whether this interaction takes place in vivo, coimmunoprecipitation experiments were performed. Because of the low abundance of Sro7p ([@bib10]; [@bib17]), Sro7p and HA-tagged Sec4p or, as a control, HA-tagged Ypt1p, were cooverexpressed in yeast. The HA-tagged Rab proteins were immunoprecipitated using an α-HA antibody, and coimmunoprecipitating Sro7p was detected by Western blotting with an α-Sro7p antibody. As shown in [Fig. 4](#fig4){ref-type="fig"}, Sro7p coimmunoprecipitates with HA-Sec4p. This interaction is specific because (1) only a background amount of Sro7p is found to interact with Ypt1p; (2) the signal requires the cooverexpression of both Sec4p and Sro7p; and (3) no signal can be detected when the antibody is omitted from the precipitation reaction ([Fig. 4](#fig4){ref-type="fig"}). These data further support the conclusion that Sro7p binds directly to Sec4p because no third protein was overexpressed. Quantification of the interaction revealed that ∼2% of total Sro7p bound to GST-Sec4p (immunoprecipitated amount set to 100%). This relatively low amount might reflect the predominantly inactivated state of Sec4p in a yeast lysate. Together, our in vivo and in vitro data establish Sro7p as an effector of Sec4p.

![**Sro7p coimmunoprecipitates with Sec4p.** Yeast cells overexpressing HA-Sec4p and Sro7p, HA-Ypt1p and Sro7p, HA-Sec4p alone, or none of these proteins were lysed, and HA-Sec4p and HA-Ypt1p were immunoprecipitated using a rat α-HA antibody (α-HA \[IP\]). Proteins were subsequently subjected to Western blot analysis, and coimmunoprecipitating Sro7p was detected using an Sro7p-specific antibody (α-Sro7). A mouse α-HA antibody (α-HA) was used to detect the precipitated HA-Sec4p and HA-Ypt1p. The specificity of the observed coimmunoprecipitation was shown by omitting the antibody from the reaction (α-HA \[IP\], − lane). The amount of HA-Sec4p and HA-Ypt1p shown represents 5% of the immunoprecipitation. The inputs represent 0.15% of total protein.](jcb1720055f04){#fig4}

Sec4p, Sro7p, and Sec9p form a trimeric complex
-----------------------------------------------

Sro7p and its paralogue, Sro77p, belong to the lgl tumor suppressor family ([@bib22]; [@bib24]; [@bib25]). Both proteins have been found to localize to the plasma membrane and to be required for exocytosis in yeast ([@bib22]; [@bib24]; [@bib25]). Moreover, it has been shown that Sro7p binds to the plasma membrane t-SNARE Sec9p and that this interaction is required for Sro7p\'s function ([@bib25]; [@bib9]). Although no direct, GTP-specific interaction of Sec4p with SNAREs was previously found ([@bib13]), our data suggested the possibility that GTP-Sec4p indirectly signals to SNAREs via Sro7p. To explore this possibility, we performed in vitro binding assays using recombinant GST-Sec4p, Sec9p, and purified Sro7p. As shown in [Fig. 5](#fig5){ref-type="fig"}, Sec9p interacts with Sec4p, but only in the presence of GTPγS and Sro7p. Under the conditions used in this assay, ∼5--10% of the input Sro7p binds to Sec4p. Only background binding of Sec9p to GTPγS-Sec4p was observed when Sro7p was omitted from the binding assay, suggesting that Sec9p binds to Sec4p through Sro7p and implying that Sec4p and Sec9p use different binding sites on Sro7p ([Fig. 5](#fig5){ref-type="fig"}). The specificity of this interaction was demonstrated by the fact that no significant binding of Sro7p or Sec9p to GDP-Sec4p or GST was detected ([Fig. 5](#fig5){ref-type="fig"}, GST). Therefore, our data imply that GTP-Sec4p, Sro7p, and Sec9p are able to form a ternary complex.

![**Sec4p, Sro7p, and Sec9p form a nucleotide-dependent ternary complex.** Glutathione beads with 4 μM of either GTPγS- or GDP-loaded GST-Sec4p (Sec4) or GST alone in the presence of GTPγS were incubated with either purified Sro7p (Sro7) or recombinant Sec9-His~6~p (Sec9) or both at 1 μM concentrations at 4°C. Copurifying Sro7p or Sec9-His~6~p were detected by Western blotting using an Sro7p-specific (α-Sro7) or Sec9p-specific (α-Sec9) antibody. The input lanes represent 5% of the total Sro7p or Sec9-His~6~p. Coomassie staining is shown as a loading control. The asterisk indicates a contaminating protein present on the GST-Sec4 beads that cross reacts with the α-Sec9 antibody.](jcb1720055f05){#fig5}

Sro7p interacts genetically with Sec3p, a subunit of the exocyst complex
------------------------------------------------------------------------

Our data suggest that Sec4p might play a role in SNARE regulation via its effector, Sro7p. The other known effector of Sec4p is Sec15p, a member of the exocyst complex ([@bib15]). The exocyst is required for the tethering of secretory vesicles to the plasma membrane ([@bib42]; [@bib14]), a step that precedes the final SNARE-mediated fusion of those vesicles with the plasma membrane. If Sro7p and the exocyst act in converging pathways, each downstream of Sec4p, the overexpression of Sro7p might be expected to compensate for the loss of exocyst function, and, conversely, the loss of Sro7p would exacerbate the phenotype of exocyst mutants. As shown in [Fig. 6](#fig6){ref-type="fig"} A, overexpression of *SRO7* on a 2μ plasmid partially rescues the temperature sensitivity of a *sec3*Δ mutant. In agreement with this, it has recently been published that the overexpression of *SRO7* rescues the exocytosis defect of the *sec3*Δ mutant ([@bib51]). Interestingly, however, the level of suppression achieved by overexpression of *SRO7* is not as strong as that achieved by 2μ *SEC4* ([Fig. 6](#fig6){ref-type="fig"} A, compare *sec3*Δ 2μ *SRO7* with *sec3*Δ 2μ *SEC4*). We found that the deletion of *SEC3* increases the doubling time of a yeast strain about twofold compared with wild-type yeast at 30°C in synthetic complete (SC) minimal medium (225 ± 21 min vs. 125 ± 7 min; [Fig. 6](#fig6){ref-type="fig"} B). Overexpression of *SEC4* rescues this growth defect to nearly wild-type levels (145 ± 7 min), but *sec3*Δ cells overexpressing *SRO7* still display a strong growth defect (190 ± 14 min; [Fig. 6](#fig6){ref-type="fig"} B). Similarly, 2μ *SRO7* does not suppress the lethality of *sec3*Δ on yeast peptone dextrose (YPD) media ([Fig. 6](#fig6){ref-type="fig"} C; [@bib47]). One interpretation of these data is that Sec4p signals to other effectors in addition to Sro7p and the exocyst to achieve vesicle fusion. In support of our suggestion of converging functions for Sro7p and the exocyst, deletion of *SRO7* in a *sec3*Δ strain further aggravates its growth defect ([Fig. 7](#fig7){ref-type="fig"} A). We observed that the doubling time of a *sec3*Δ *sro7*Δ strain (360 ± 28 min) is almost twice that of a *sec3*Δ single mutant strain (225 ± 21 min; [Fig. 7](#fig7){ref-type="fig"} B). This growth phenotype is accompanied by a significant drop in exocytosis in the *sec3*Δ *sro7*Δ mutant of ∼10% compared with the *sec3*Δ mutant (73 ± 7% vs. 60 ± 5% of secreted invertase; [Fig. 7](#fig7){ref-type="fig"} C). This further implicates Sro7p and the exocyst in interrelated functions on the exocytic pathway.

![**Overexpression of *SRO7* partially suppresses the growth defect of a *sec3*Δ strain.** (A) Wild-type (WT), *sec3*Δ, and *sec3*Δ yeast strains overexpressing either *SEC4* (*sec3*Δ 2μ *SEC4*) or *SRO7* (*sec3*Δ 2μ *SRO7*) from a 2μ plasmid were spotted onto SC media plates in 10-fold dilutions and grown at the indicated temperatures. (B) Wild-type, *sec3*Δ, and *sec3*Δ yeast strains overexpressing either *SEC4* (*sec3*Δ 2μ *SEC4*) or *SRO7* (*sec3*Δ 2μ *SRO7*) on 2μ plasmids were grown at 30°C in SC media. The doubling time was measured by plotting OD~600~ over time. The mean of three independent experiments is shown. Error bars represent SEM. (C) Wild-type, *sec3*Δ, and *sec3*Δ yeast strains overexpressing either *SEC4* (*sec3*Δ 2μ *SEC4*) or *SRO7* (*sec3*Δ 2μ *SRO7*) on a 2μ plasmid were spotted onto a YPD plate in 10-fold dilutions and grown at 24°C.](jcb1720055f06){#fig6}

![**Loss of** *SRO7* **exacerbates the *sec3Δ* phenotype.** (A) Wild-type (WT), *sro7*Δ, *sec3*Δ, and *sec3*Δ *sro7*Δ yeast strains were spotted onto SC media plates in 10-fold dilutions and grown at the indicated temperatures. (B and C) Wild-type, *sec3*Δ, and *sec3*Δ *sro7*Δ yeast strains were grown at 30°C in SC media. (B) The doubling time was measured by plotting OD~600~ over time. The mean of three independent experiments is shown. (C) Deletion of *SRO7* in a *sec3*Δ strain leads to a more pronounced defect in exocytosis. Expression of the enzyme invertase was derepressed by shifting the strains into low glucose medium, and secretion of invertase was measured after 1 h of derepression by a colorimetric test (see Materials and methods). Values indicate percentages of secreted invertase. A mean of four different experiments is shown. Error bars represent SEM.](jcb1720055f07){#fig7}

Because we observed a synthetic growth defect in the *sec3*Δ *sro7*Δ mutant strain, we decided to test whether the deletion of *SRO7* would have a similar influence on the growth of other exocyst mutant strains. For that purpose, we used a collection of temperature-sensitive late secretory mutant strains (*sec1-1*, *sec2-41*, *sec3-2*, *sec4-8*, *sec5-24*, *sec6-4*, *sec8-9*, *sec9-4*, *sec10-2*, and *sec15-1*). We observed that *sec2-41*, *sec3-2*, *sec4-8, sec8-9*, *sec9-4,* and *sec15-1* in combination with *sro7*Δ displayed slower growth compared with the single mutant strains at the permissive temperature of 24°C (Fig. S1, available at <http://www.jcb.org/cgi/content/full/jcb.200510016/DC1>). Interestingly, the most striking feature we observed is that combining a deletion of *SRO7* with almost all of the heat-sensitive mutants lead to a synthetic growth defect at 14°C ([Table II](#tbl2){ref-type="table"} and Fig. S1). Double deletion of *SRO7* and its paralogue *SRO77* has been found to lead to cold sensitivity of the resulting double mutant strain ([@bib22]; [@bib25]), which demonstrated that their gene products share a common function. We found that the double mutants of the Rab GTPase Sec4p (*sec4-8*) or its GEF Sec2p (*sec2-41*) with *sro7*Δ display synthetic lethality at 14°C ([Table II](#tbl2){ref-type="table"} and Fig. S1). This result further indicates a common function of Sro7p and Sec4p. The fact that *sro7*Δ causes *sec1-1*, a heat-sensitive mutant of the SNARE-interacting protein Sec1p, and *sec9-4*, a mutant of the t-SNARE Sec9p, to become cold sensitive ([Table II](#tbl2){ref-type="table"} and Fig. S1) adds genetic evidence for a role of Sro7p in SNARE function in yeast. Interestingly, we also found that the deletion of *SRO7* leads to cold sensitivity in only a subset of the temperature-sensitive exocyst mutant strains ([Table II](#tbl2){ref-type="table"} and Fig. S1). These data might either reflect the relative strength of these mutant alleles at low temperature or indicate that only those subunits share a function with Sro7p and, therefore, add further evidence for a functional specialization of exocyst subunits within the complex ([@bib48]). Altogether, our genetic data support a possible role for Sro7p in transferring the signal of the Rab GTPase Sec4p to SNARE function in yeast.

###### 

**Synthetic growth defects of temperature-sensitive secretory mutant strains when combined with** *sro7* **Δ**

  Mutant            Growth at 14°C
  ----------------- -------------------------------------
  *sec1-1 sro7*Δ    Slow
  *sec9-4 sro7*Δ    Slow
  *sec2-41 sro7*Δ   None
  *sec4-8 sro7*Δ    None
  *sec3-2 sro7*Δ    None
  *sec5-24 sro7*Δ   Wild type--like
  *sec6-4 sro7*Δ    Wild type--like
  *sec8-9 sro7*Δ    None
  *sec10-2 sro7*Δ   Slow[a](#tfn1){ref-type="table-fn"}
  *sec15-1 sro7*Δ   None

Single temperature-sensitive mutant strains grow comparably with wild-type yeast at 14°C. Double temperature-sensitive *sro7*Δ mutant strains display the indicated synthetic growth phenotypes at this temperature after growth for 7 d.

Only slight growth defects were observed.

Genetic evidence for a role of Sro7p downstream of Sec4p
--------------------------------------------------------

Although Sec3p is the only nonessential exocyst protein ([@bib47]), a previous study revealed that *SEC5* and *EXO70* also could be deleted if either Sec4p or Sec1p were overproduced ([@bib48]). Given our data that overproduction of Sro7p rescues the growth defect of a *sec3*Δ mutant strain, we hypothesized that 2μ *SRO7* might also be able to overcome the lethality of *exo70*Δ and *sec5*Δ mutant strains. As shown in [Fig. 8](#fig8){ref-type="fig"}, overexpression of *SRO7* on a 2μ plasmid indeed rescues the lethality of both *exo70*Δ ([Fig. 8](#fig8){ref-type="fig"} A) and *sec5*Δ ([Fig. 8](#fig8){ref-type="fig"} B) mutant strains. Because we found that Sro7p is an effector of Sec4p with an exocyst-related function, it appeared likely that Sro7p would be required for the Sec4p-mediated rescue of *exo70*Δ and *sec5*Δ mutant strains ([@bib48]). Indeed, the deletion of *SRO7* reduces the growth of both *exo70*Δ and *sec5*Δ strains rescued by the overexpression of *SEC4* from a 2μ plasmid ([Fig. 9, A and B](#fig9){ref-type="fig"}; compare *exo70*Δ 2μ *SEC4* or *sec5*Δ 2μ *SEC4* with *exo70*Δ *sro7*Δ 2μ *SEC4* or *sec5*Δ *sro7*Δ 2μ *SEC4*). We found that the doubling times of the *exo70*Δ *sro7*Δ 2μ *SEC4* (240 ± 21 min) or *sec5*Δ *sro7*Δ 2μ *SEC4* (242 ± 31 min) yeast strains are significantly increased compared with the yeast strains without additional deletion of *SRO7* (190 ± 14 min and 185 ± 21 min, respectively; [Fig. 9, C and D](#fig9){ref-type="fig"}). In striking contrast, deletion of *SRO7* was found to only have minor influences on the growth of both *exo70*Δ and *sec5*Δ mutant strains rescued by overexpression of *SEC1* from a 2μ plasmid on either solid or liquid media ([Fig. 9](#fig9){ref-type="fig"}, compare *exo70*Δ 2μ *SEC1* or *sec5*Δ 2μ *SEC1* with *exo70*Δ *sro7*Δ 2μ *SEC1* or *sec5*Δ *sro7*Δ 2μ *SEC1*). Therefore, these data provide genetic evidence that Sro7p functions downstream of Sec4p in an exocyst-related function. They further imply that although Sec4p signaling is upstream of Sro7p and the exocyst, Sec1p functions downstream of both (summarized in the model in [Fig. 10](#fig10){ref-type="fig"}). Our results are also consistent with previous data that showed that Sec4p and Sec1p use different mechanisms for suppression of exocyst deletion mutations ([@bib48]).

![**Overexpression of** *SRO7* **suppresses the lethality of deletion of *EXO70* and *SEC5*.** (A) Wild-type (WT) and *exo70*Δ yeast strains overexpressing either *SEC4* (*exo70*Δ 2μ *SEC4*), *SEC1* (*exo70*Δ 2μ *SEC1*), or *SRO7* (*exo70*Δ 2μ *SRO7*) were spotted onto SC media plates in 10-fold dilutions and grown at the indicated temperatures. (B) Wild-type and *sec5*Δ yeast strains overexpressing either *SEC4* (*sec5*Δ 2μ *SEC4*), *SEC1* (*sec5*Δ 2μ *SEC1*), or *SRO7* (*sec5*Δ 2μ *SRO7*) were spotted onto SC media plates in 10-fold dilutions and grown at the indicated temperatures.](jcb1720055f08){#fig8}

![**Sro7p is required for the suppression of** *exo70* **Δ and *sec5Δ* lethality by the overexpression of *SEC4*.** (A and B) Wild-type (WT) yeast, *exo70*Δ (A) or *sec5*Δ (B) single, and *exo70*Δ *sro7*Δ (A) or *sec5*Δ *sro7*Δ (B) double mutant strains overexpressing *SEC4* (2μ *SEC4*) or *SEC1* (2μ *SEC1*) were spotted onto SC media plates in 10-fold dilutions and grown at the indicated temperatures. (C and D) Wild-type yeast, *exo70*Δ (C) or *sec5*Δ (D) single, and *exo70*Δ *sro7*Δ (C) or *sec5*Δ *sro7*Δ (D) double mutant strains overexpressing *SEC4* (2μ *SEC4*) or *SEC1* (2μ *SEC1*) were grown at 30°C in SC media. The doubling time was measured by plotting OD~600~ over time. The mean of two independent experiments is shown. Error bars represent SEM.](jcb1720055f09){#fig9}

![**Model for the Sec4p signaling pathways.** Secretory vesicles (V) carry the Rab GTPase Sec4p and its GEF Sec2p, which keeps Sec4p in its activated, GTP-bound state. Sec15p, a member of the exocyst complex, is one effector for Sec4p, and the interaction of these two proteins is required for the assembly of this complex and its tethering function in exocytosis ([@bib15]). Sec1p interacts with the exocyst ([@bib48]) and binds to assembled SNARE complexes, possibly stabilizing them ([@bib5]). Another effector of Sec4p, Sro7p (this study), interacts with the exocytic t-SNARE Sec9p ([@bib25]), and genetic data indicate that this interaction is required for Sec4p\'s role in exocytosis ([@bib4]; [@bib25]; and this study). A recent study showed that the exocyst and the yeast lgl family members interact ([@bib51]), allowing an integrated response. Arrows indicate physical interactions.](jcb1720055f10){#fig10}

Sro7p does not bypass all exocyst functions
-------------------------------------------

Given the fact that both Sro7p and the exocyst are Sec4p effectors and that the overexpression of *SRO7* suppresses the phenotypes of three different exocyst deletions, it appeared possible that Sro7p would be able to completely bypass the exocyst, which would imply that Sro7p and the exocyst have identical functions. We assessed this possibility by investigating whether the overexpression of *SRO7* (or, if necessary, *SRO7* in combination with *SEC4*) would rescue the lethality of a *sec15*Δ strain. Sec15p is the subunit of the exocyst that directly interacts with Sec4p ([@bib15]). It has been previously shown that the overexpression of *SEC4* and *SRO7* was able to suppress the temperature sensitivity of a *sec15-1* mutant strain (Fig. S2 A, available at <http://www.jcb.org/cgi/content/full/jcb.200510016/DC1>; [@bib36]; [@bib15]; [@bib25]). However, under all tested conditions (different media and temperatures), neither 2μ *SRO7* nor 2μ *SRO7* in combination with 2μ *SEC4* were able to suppress the lethality of a *sec15*Δ strain (Fig. S2 B and not depicted). These genetic data indicate that Sro7p shares some, but not all, functions with the exocyst in yeast.

Discussion
==========

Sro7p is an effector of the secretory Rab GTPase Sec4p
------------------------------------------------------

Sec4p is a member of the Rab GTPase family that plays important roles in the yeast secretory pathway ([@bib36]; [@bib11]). Only one effector for Sec4p was known before this study: the exocyst subunit Sec15p ([@bib15]). We described the identification by affinity chromatography of a second Sec4p effector, Sro7p, which is a member of the lgl family of tumor suppressors ([@bib22]; [@bib24]; [@bib25]). We have shown that Sec4p and Sro7p interact in vitro and in vivo and that the interaction requires Sec4p to be in its activated, GTP-bound state ([Figs. 2](#fig2){ref-type="fig"}--[5](#fig5){ref-type="fig"}). Our data establish Sro7p as an effector of Sec4p and provide further support for a role of lgl family members in membrane traffic (see Introduction).

Several previously published reports support our findings. Sro7p and its paralogue Sro77p were originally identified as high-copy suppressors of Rho3p ([@bib29]; [@bib22]), which is a Rho GTPase required for actin cytoskeleton polarity and polarized exocytosis in yeast ([@bib30]; [@bib19]; [@bib1]). Another protein found in this screen (Sro6p) was subsequently identified as Sec4p. These genetic data suggest that the identified proteins positively influence cell polarity and/or polarized exocytosis, as had been shown for Sec4p ([@bib36]; [@bib11]). Subsequently, Sro7/77p have also been found to be required for exocytosis in yeast ([@bib25]). Additionally, the overexpression of Sro7p was found to suppress the cold sensitivity of a *sec4-P48* mutant ([@bib4]), which suggested that Sro7p might act downstream of Sec4p function.

Sro7p genetically interacts with the exocyst downstream of Sec4p
----------------------------------------------------------------

Genetic data presented in this study indicate that the function of Sro7p partially overlaps with that of the exocyst ([Figs. 6](#fig6){ref-type="fig"}--[9](#fig9){ref-type="fig"}), an eight-subunit vesicle-tethering complex required for tethering secretory vesicles to the plasma membrane ([@bib42]; [@bib14]). We found that the overexpression of *SRO7* suppresses the growth defects of three different exocyst deletion mutants (*sec3*Δ, *sec5*Δ, and *exo70*Δ; [Figs. 6](#fig6){ref-type="fig"} and [8](#fig8){ref-type="fig"}), extending recently published data ([@bib51]). We also showed that the deletion of *SRO7* impairs the growth and secretory function of a *sec3*Δ strain ([Fig. 7](#fig7){ref-type="fig"}), which further implies that Sro7p and the exocyst function in concert.

We recently established that the overexpression of either Sec4p or Sec1p can bypass the inviability of *sec5*Δ or *exo70*Δ strains ([@bib48]). Interestingly, we now demonstrate that the deletion of *SRO7* in *exo70*Δ or *sec5*Δ strains reduces growth only when *SEC4* is overexpressed ([Fig. 9](#fig9){ref-type="fig"}). If *SEC1* is overexpressed, no significant difference in growth can be detected upon *SRO7* deletion ([Fig. 9](#fig9){ref-type="fig"}). These data provide genetic evidence that Sro7p acts downstream of Sec4p in its capacity as a suppressor and demonstrate that Sro7p is involved in a Sec4p- and exocyst-related function ([Fig. 10](#fig10){ref-type="fig"}). Moreover, they further strengthen the findings by [@bib48] that indicate that Sec4p and Sec1p use different mechanisms in their suppression of the two exocyst mutants.

Although *SRO7, SEC1*, and *SEC4* can each act as a high-copy suppressor of *sec3*Δ*, sec5*Δ, and *exo70*Δ*,* there is no simple hierarchy in the efficiency of suppression. Thus, *SEC4* suppresses *sec3*Δ and *sec5*Δ better than does *SRO7* ([Figs. 6](#fig6){ref-type="fig"} and [8](#fig8){ref-type="fig"}), but *SRO7* is somewhat better at suppressing *exo70*Δ than is *SEC4* ([Fig. 8](#fig8){ref-type="fig"}). Furthermore, *SEC1* suppresses *exo70*Δ much better than does *SEC4*, but *SEC4* suppresses *sec5*Δ much better than does *SEC1* ([Fig. 8](#fig8){ref-type="fig"}). Although this pattern is presently difficult to interpret, it does support the notion that different subunits of the exocyst fulfill distinct functions ([@bib48]), possibly in tethering and regulation of SNARE function.

As mentioned above, the Sec15p subunit of the yeast exocyst is also a Sec4p effector ([@bib15]). If Sro7p and the exocyst have purely redundant functions downstream of Sec4p, the overexpression of one effector should overcome the loss of the other. Contrary to this prediction, we found that overexpression of *SRO7,* either alone or in combination with *SEC4,* did not suppress the lethality of a *sec15*Δ mutant under all conditions tested (Fig. S2 B and not depicted). Thus, these data indicate that Sro7p and the exocyst have interrelated but not identical functions. In agreement with this, the overexpression of individual exocyst subunits did not suppress the salt sensitivity of the *sro7*Δ mutant (Fig. S3, available at <http://www.jcb.org/cgi/content/full/jcb.200510016/DC1>) or the cold sensitivity of an *sro7*Δ *sro77*Δ mutant ([@bib51]). Although it might simply be that more than one subunit (i.e., a subcomplex) is required for suppression, another explanation for this finding is that Sro7p and Sro77p have important cellular functions beyond their role in exocytosis. In agreement with this, overexpression of either of the t-SNAREs, *SEC9* and *SSO1*, or the SNARE regulator *SEC1* failed to suppress the *sro7*Δ *sro77*Δ phenotype ([@bib51]). Sro7/77p have been shown to interact biochemically with the yeast type II myosin Myo1p, an interaction that appears to play a role in the remodeling of the actin cytoskeleton ([@bib22]), which is consistent with data concerning lgl family members from other organisms (see Introduction). Another explanation for the failure of overexpression of single exocyst subunits to suppress the salt or cold sensitivity of Sro7/77p mutants could be that Sro7p and Sro77p act downstream of some, but not all, aspects of exocyst function ([@bib48]; [@bib51]).

Sro7p links a Rab (Sec4p) to a t-SNARE (Sec9p)
----------------------------------------------

Rab GTPase activity has previously been implicated in the regulation of SNARE complex assembly ([@bib26]; [@bib39]). Furthermore, genetic evidence suggested that plasma membrane SNAREs act in response to Rabs because the overexpression of *SEC9* has been found to suppress the growth defect of a *sec4-P48* mutant strain ([@bib4]). Nonetheless, a direct interaction of activated Sec4p and the exocytic SNAREs could not be detected ([@bib13]). We provide evidence in this study that GTP-bound Sec4p interacts with the plasma membrane SNAREs via Sro7p. The Sec4p effector Sro7p was found to interact with the t-SNARE Sec9p ([@bib25]), and recent data indicate that this interaction is important for Sro7p\'s function in secretion ([@bib9]). We have demonstrated that Sec9p can associate with Sec4p, but only in the presence of GTPγS and Sro7p ([Fig. 5](#fig5){ref-type="fig"}). This interaction provides a link between Rab signaling and SNARE function in yeast exocytosis.

Together, two convergent signaling pathways from the Rab GTPase Sec4p appear to lead to vesicle fusion in yeast ([Fig. 10](#fig10){ref-type="fig"}). Secretory vesicles carrying activated Sec4p transmit a signal to Sec15p, which leads to exocyst assembly and vesicle tethering ([@bib15]). A recently documented association of Sec1p with the exocyst ([@bib48]) potentially links this pathway to SNARE function. In a second branch of the pathway, Sec4p transmits a signal through the lgl family member Sro7p. Because Sec4p, Sro7p, and the t-SNARE Sec9p can assemble into a ternary complex, we propose that Sro7p conveys the signal from the Rab GTPase to SNARE function in yeast. These interactions may normally occur after vesicle tethering by the exocyst. There appears to be crosstalk between these two pathways because Sro7p has recently been shown to associate with the exocyst subunit Exo84p ([@bib51]). Further studies will be necessary to explore these proposals.

Materials and methods
=====================

Yeast strains and genetic analysis
----------------------------------

*S. cerevisiae* strains used in this study are listed in [Table III](#tbl3){ref-type="table"}. Standard techniques and media were used for growth, mating, sporulation, tetrad dissection, and yeast transformation ([@bib20]; [@bib38]). Most yeast strains were created by mating appropriate parent strains. The resulting diploids were sporulated and dissected, and appropriate spores were picked. Strain NY 2587 was created by using a PCR-based method ([@bib27]). NY 2592--2595 were made by transforming combinations of plasmids pNB 529, pNB 833, or pNB 829 and either pNB 530 or pNB 1246 into NY 1210. Overexpression of HA-Sec4p, HA-Ypt1p, and Sro7p was confirmed by Western blotting. NY 2602 and 2603 were created by transforming pNB 142 or pB 745 into the appropriate diploid yeast strain before dissection. Strains NY 2609 and NY 2610 were made by streaking diploids (NY 2590 × NY 2478 or NY 2590 × NY 2476) onto SC medium containing 5-FOA (1 mg/ml final concentration) to select cells that lost the 2μ *SEC1* plasmid. Subsequently, these diploid cells were transformed with plasmid pB 745, were sporulated and dissected, and the appropriate spores were picked.

###### 

**Yeast strains**

  ----------------------------------------------------------------------------------------------------------------------------------
  Yeast strain   Description                                                                                 Source
  -------------- ------------------------------------------------------------------------------------------- -----------------------
  NY 1210        Mata *ura3-52 leu2-3,112 his3-*Δ*200 GAL*+                                                  P. Novick collection

  BY 570         Matα *sro7*Δ*::LEU2 leu2-3,112 ura3-52 his3-*Δ*200*                                         [@bib25]

  BY 569         Mata *sro77*Δ*::URA3 leu2-3,112 ura3-52 his3-*Δ*200*                                        [@bib25]

  NY 2587        Mata *SRO7-HA* ~3~::*kanMX ura3-52 leu2-3,112 his3-*Δ*200* GAL+                             This study

  NY 2588        Mata *sro7*Δ*::LEU2 sro77*Δ*::URA3 leu2-3,112 ura3-52 his3-*Δ*200*                          This study; based on\
                                                                                                               [@bib25]

  NY 2589        Mata *SRO7-HA* ~3~::LEU2 sro77Δ*::URA3 leu2-3,112 ura3-52 his3-*Δ*200*                      This study

  NY 2592        Mata *P* ~Gal1~::*SRO7::URA3 P~Gal1~::HASEC4::LEU2 ura3-52 leu2-3,112 his3-*Δ*200* GAL+     This study

  NY 2593        Mata *P* ~Gal1~::*URA3 P~Gal1~::HA-SEC4::LEU2 ura3-52 leu2-3,112 his3*-Δ*200* GAL+          This study

  NY 2594        Mata *P* ~Gal1~::*SRO7::URA3 P~Gal1~::HA-YPT1::LEU2 ura3-52 leu2-3,112 his3*-Δ*200* GAL+    This study

  NY 2595        Mata *P* ~Gal1~::*URA3 P~Gal1~::LEU2 ura3-52 leu2-3,112 his3*-Δ*200* GAL+                   This study

  NY 2448        Matα *sec3*Δ*::kanMX ura3-52 leu2-3,112 his3-*Δ*200*                                        [@bib47]

  NY 2601        Mata *sec3*Δ*::kanMX sro7*Δ*::LEU2 ura3-52 leu2-3,112 his3-*Δ*200*                          This study

  NY 2602        Matα *sec3*Δ*::kanMX ura3-52 leu2-3,112 his3-*Δ*200* 2μ *SEC4::URA3*                        This study

  NY 2603        Matα *sec3*Δ*::kanMX ura3-52 leu2-3,112 his3-*Δ*200* 2μ *SRO7::URA3*                        This study

  NY 2479        Matα *exo70*Δ*::kanMX leu2-3,112 ura3-52* 2μ *SEC4::URA3*                                   [@bib48]

  NY2478         Matα *exo70*Δ*::kanMX leu2-3,112 ura3-52* 2μ *SEC1::URA3*                                   [@bib48]

  NY 2604        Matα *exo70*Δ*::kanMX sro7*Δ*::LEU2 leu2-3,112 ura3-52* 2μ *SEC4::URA3*                     This study

  NY 2605        Matα *exo70*Δ*::kanMX sro7*Δ*::LEU2 leu2-3,112 ura3-52* 2μ *SEC1::URA3*                     This study

  NY 2477        Matα *sec5*Δ*::kanMX leu2-3,112 ura3-52* 2μ *SEC4::URA3*                                    [@bib48]

  NY 2476        Matα *sec5*Δ*::kanMX leu2-3,112 ura3-52* 2μ *SEC1::URA3*                                    [@bib48]

  NY 2607        Mata *sec5*Δ*::kanMX sro7*Δ*::LEU2 leu2-3,112 ura3-52* 2μ *SEC4::URA3*                      This study

  NY 2608        Matα *sec5*Δ*::kanMX sro7*Δ*::LEU2 leu2-3,112 ura3-52* 2μ *SEC1::URA3*                      This study

  NY 2609        Matα *exo70*Δ*::kanMX leu2-3,112 ura3-52* 2μ *SRO7::URA3*                                   This study

  NY 2610        Matα *sec5*Δ*::kanMX leu2-3,112 ura3-52* 2μ *SRO7::URA3*                                    This study

  NY 68          Mata *sec15-1 his4-619 ura3-52*                                                             P. Novick collection

  NY 2421        *sec15*Δ*::kanMX/SEC15 leu2*Δ*0/leu2*Δ*0 ura3*Δ*0/ura3*Δ*0 met15*Δ*0/MET15 lys2*Δ*0/LYS2*   EUROSCARF collection

  NY 605         Mata *ura3-52 leu2-3,112* Gal+                                                              P. Novick collection

  NY 768         Matα *sec1-1 ura3-52 leu2-3,112*                                                            P. Novick collection

  NY 770         Matα *sec2-41 ura3-52 leu2-3,112*                                                           P. Novick collection

  NY772          Mata *sec3-2 ura3-52 leu2-3,112*                                                            P. Novick collection

  NY 774         Matα *sec4-8 ura3-52 leu2-3,112*                                                            P. Novick collection

  NY 776         Matα *sec5-24 ura3-52 leu2-3,112*                                                           P. Novick collection

  NY 778         Matα *sec6-4 ura3-52 leu2-3,112*                                                            P. Novick collection

  NY 780         Matα *sec8-9 ura3-52 leu2-3,112*                                                            P. Novick collection

  NY 782         Mata *sec9-4 ura3-52 leu2-3,112*                                                            P. Novick collection

  NY 784         Mata *sec10-2 ura3-52 leu2-3,112*                                                           P. Novick collection

  NY 786         Mata *sec15-1 ura3-52 leu2-3,112*                                                           P. Novick collection

  NY 2611        Mata *sec1-1 sro7*Δ*::LEU2 ura3-52 leu2-3,112*                                              This study

  NY 2612        Mata *sec2-41 sro7*Δ*::LEU2 ura3-52 leu2-3,112*                                             This study

  NY 2613        Matα *sec3-2 sro7*Δ*::LEU2 ura3-52 leu2-3,112*                                              This study

  NY 2614        Matα *sec4-8 sro7*Δ*::LEU2 ura3-52 leu2-3,112*                                              This study

  NY 2615        Matα *sec5-24 sro7*Δ*::LEU2 ura3-52 leu2-3,112*                                             This study

  NY 2616        Matα *sec6-4 sro7*Δ*::LEU2 ura3-52 leu2-3,112*                                              This study

  NY 2617        Matα *sec8-9 sro7*Δ*::LEU2 ura3-52 leu2-3,112*                                              This study

  NY 2618        Mata *sec9-4 sro7*Δ*::LEU2 ura3-52 leu2-3,112*                                              This study

  NY 2619        Mata *sec10-2 sro7*Δ*::LEU2 ura3-52 leu2-3,112*                                             This study

  NY 2620        Mata *sec15-1 sro7*Δ*::LEU2 ura3-52 leu2-3,112*                                             This study
  ----------------------------------------------------------------------------------------------------------------------------------

For genetic analysis, at least two different spores were analyzed per experiment. For dot spot analysis, stationary yeast cultures were diluted to an OD~600~ of ∼0.3, and 10-fold dilutions were spotted onto YPD media or SC plates and incubated at the indicated temperatures for 2--3 (25°C and above) or 7--8 (14°C) d.

Plasmids
--------

Standard techniques were used for plasmid construction. The *SEC4* ORF was amplified by PCR from genomic DNA and subsequently inserted into plasmid pGEX5X-1 (GE Healthcare) to create the GST-*SEC4* expression vector (pNB 1245). The plasmid carrying GST-*YPT1* was described previously ([@bib46]).

The plasmid carrying *SRO7* behind the *GAL1* promoter (pNB 1246) was created by inserting the *SRO7* ORF into plasmid pNB 530 (*GAL1* promoter, *ADH1* terminator, and *URA3* marker). The plasmids carrying *HA-SEC4* (pNB 833) and *HA-YPT1* (pNB 829) behind the *GAL1* promoter and the control plasmid pNB 529 have been described previously ([@bib13]).

Plasmid pB 745 (2μ *SRO7::URA3*) was described previously ([@bib25]). 2μ plasmids pNB 142, 680, 807, 690, 216, 328, 685, 148, 887, and 888 were used to overexpress *SEC4*, *SEC1*, *SEC3*, *SEC5*, *SEC6*, *SEC8*, *SEC10*, *SEC15*, *EXO70,* or *EXO84*, respectively (P. Novick collection).

Antibodies
----------

The α-Sro7p antibody was described previously ([@bib25]). Clones 3F10 (rat monoclonal; Roche) and 16B12 (mouse monoclonal; Convance) were used as antibodies against the HA epitope. Rabbit polyclonal antibodies were used for the detection of Sec2p or Sec15p (P. Novick collection). A goat α-GST antibody (Sigma-Aldrich) was used to detect GST fusion proteins.

Yeast extract for Sec4p affinity chromatography
-----------------------------------------------

27 liters of wild-type yeast culture were lysed by homogenization in a microfluidizer (Microfluidics Corporation) in 140 ml of nucleotide-binding (NB) buffer (20 mM Hepes, pH 7.2, 100 mM KCl, 5 mM MgCl~2~, and 1 mM DTT) containing 1 mM PMSF, 5 μg/ml pepstatin A, and complete protease inhibitor EDTA-free cocktail (Roche). Triton X-100 was added to 1%, and unbroken cells and debris were eliminated by centrifugation at 10,000 *g* for 25 min at 4°C. The extract was dialyzed against NB buffer overnight. The concentration of the extract was adjusted to 40 mg/ml.

Purification of GST-Sec4, GST-Ypt1, and GST and nucleotide exchange
-------------------------------------------------------------------

GST fusion proteins were purified from BL21 *Escherichia coli* strains (Novagen) as described previously ([@bib6]; [@bib46]; [@bib18]). For nucleotide loading, GST-Sec4p or GST-Ypt1p were incubated with a 200-fold excess of either GTPγS or GDP in NB for 2 h at 30--37°C. To obtain the nucleotide-free state, the proteins were incubated in NB buffer supplemented with 10 mM EDTA.

Purification of full-length Sec9 and Sro7
-----------------------------------------

Full-length Sec9p tagged with COOH-terminal His~6~ tag was purified from *E. coli* as described previously ([@bib9]). Sro7p with an NH~2~-terminal protein A/tobacco etch virus (TEV) tag was isolated from lysates prepared from overexpressing yeast strains using affinity chromatography with IgG Sepharose beads. It was then eluted by cleavage of the protein A tag with TEV protease and subsequently purified by ion exchange chromatography to apparent homogeneity based on SDS-PAGE analysis.

Sec4p affinity chromatography
-----------------------------

The protocol was adapted from [@bib6]. In brief, 100 μl GTPγS- or GDP-bound GST-Sec4p or GST-containing beads (∼750 μg of protein) were incubated with 25 ml of wild-type yeast extract (40 mg/ml) for 2 h at 4°C. After several washings, bound proteins were eluted with elution buffer (20 mM Hepes, pH 7.2, 1.5 M NaCl, 20 mM EDTA, and 1 mM DTT) supplemented with 5 mM of the opposing nucleotide. The proteins were TCA precipitated, dried, and analyzed by mass spectrometry.

For the experiment in [Fig. 2](#fig2){ref-type="fig"}, 2.5 μl of loaded beads (∼15 μg) were incubated with 1 ml of a 20-mg/ml yeast extract (lysed using a French press; Sim-Amico Spectronic Instruments). Bound proteins were analyzed by Western blotting.

Mass spectrometry
-----------------

Samples were suspended in 8 M urea and 100 mM Tris, pH 8.5, reduced with 100 mM TCEP, and cysteines were alkylated with 55 mM iodoacetamide. Lys-C was used to digest the proteins for 4 h at 37°C at a concentration of 1 μg/100 μl. CaCl~2~ was added to ensure tryptic specificity at 1 mM, and trypsin was used to digest the samples further at 1 μg/100 μl. The digests were then analyzed by μLC/μLC-MS/MS using an ion trap mass spectrometer (LCQ Deca; ThermoElectron). Multidimensional chromatography was performed online according to [@bib28] using the following salt steps of 500 mM ammonium acetate: 10, 25, 35, 50, 65, 80, and 100%. Tandem mass spectra were collected in a data-dependent fashion by collecting one full MS scan (m/z range = 400--1,600) followed by MS/MS spectra of the three most abundant precursor ions. The collection of resulting spectra was then searched against a database of yeast ORFs obtained from the *Saccharomyces* genome database (release date 08/27/04) using the SEQUEST algorithm ([@bib8]). Peptide identifications were organized and filtered using the DTASelect program ([@bib41]). Filtering criteria for positive protein identifications in the Smt3p purification were the identification of two unique, fully tryptic peptides with Xcorr values \>2.0 for +1 spectra, 2.2 for +2 spectra, and 3.75 for +3 spectra.

In vitro binding assays
-----------------------

Glutathione beads carrying 6 μM GST-Sec4p or GST were washed with 20 mM Tris, pH 7.5, 100 mM NaCl, and 1 mM DTT and were incubated in 20 mM Tris, pH 7.5, 100 mM NaCl, 5 mM EDTA, and 1 mM DTT in the presence of either 100 μM GTPγS, 100 μM GDP, or no nucleotide for 15 min at 25°C. Then, MgCl~2~ was added to a final concentration of 25 mM and incubated 45 min at 25°C. Binding assays were performed in binding buffer (20 mM Tris-HCl, pH 7.4, 140 mM NaCl, 5 mM MgCl~2~, 1 mM DTT, and 0.5% Triton X-100). The final concentrations of GST/GST-Sec4p in the binding reactions were 4 μM, whereas concentrations of Sro7p or Sec9p were 1 μM. Samples were incubated at 4°C for 1 h. The beads were washed four times with binding buffer, and bound proteins were subjected to Western blot analysis. Sro7p and Sec9p were detected with rabbit α-Sro7 or α-Sec9 antibodies and α-rabbit IgG conjugated to AlexaFluor680 and were analyzed on an Odyssey Infrared Imaging System (LI-COR). For the experiment in [Fig. 5](#fig5){ref-type="fig"}, Sro7p--Sec9p mixtures (or Sro7p or Sec9p alone) were preincubated on ice for 1 h to allow the formation of binary complexes before their addition to the coated glutathione beads.

Immunoprecipitation
-------------------

Yeast strains 2,592--2,595 were grown overnight in yeast peptone media containing raffinose at 25°C to an OD~600~ of ∼0.4. Production of HA-Sec4p, HA-Ypt1p, and Sro7p was then induced by the addition of 2% galactose for 45 min. Cell pellets were resuspended in immunoprecipitation buffer (20 mM Hepes, pH 7.2, 150 mM KCl, 1 mM DTT, 6 mM MgCl~2~, and 1 mM EDTA) containing 1 mM GTP, 1% NP-40, and protease inhibitors (1 mM PMSF, 2 μg/ml pepstatin A, 2 μg/ml chymostatin, 2 μg/ml aprotinin, 2 μg/ml leupeptin, and 2 μg/ml antipain). 2 g zirconia-silica beads were added, and the cells were lysed by homogenization in a Mini-Bead Beater (Biospec Products). Unbroken cells and debris were eliminated by centrifugation at 10,000 *g* for 20 min at 4°C. The concentration of the yeast extracts was adjusted to 1 mg/ml, 30 μl of 50% protein G--Sepharose beads were added to 500 μl of extract, and the reaction was incubated for 90 min at 4°C. Beads were pelleted, 7.5 μl rat α-HA antibody was added to the supernatants, and the reactions were incubated overnight at 4°C. 6 μl of 50% protein G--Sepharose beads were added and incubated for another 30 min. The beads were pelleted, washed several times with immunoprecipitation buffer, and bound proteins were subjected to Western blot analysis.

Invertase secretion
-------------------

The monitoring of invertase secretion was performed as described previously ([@bib47]).

Image analysis
--------------

Data were digitalized using a scanner (HP Scanjet 4570c; Hewlett Packard).

Online supplemental material
----------------------------

Fig. S1 shows the growth of exocytic temperature-sensitive mutants combined with the deletion of *SRO7* compared with the single mutants and wild-type yeast at 24 and 14°C (data are summarized in [Table II](#tbl2){ref-type="table"}). Fig. S2 shows that the overexpression of *SEC4* and *SRO7* suppresses the growth phenotype of a *sec15-1* mutant strain (A) but not the deletion of *SEC15* (B). Fig. S3 shows that the overexpression of single exocyst subunits does not suppress the salt sensitivity of an *sro7*Δ strain.
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